FDA eCTD submission guidance
Providing Regulatory Submissions in Electronic Format: Certain Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications
Current edition
Revision 8 (September 2024)
Current edition
Revision 8 (September 2024)
About this standard
Sets the electronic format (eCTD) for NDAs, ANDAs, certain BLAs and certain INDs under section 745A(a) of the FD&C Act, with the exemptions and waivers.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Related standards: MDR 2017 Fourth Schedule, Appendix II and III, JP notification on electronic study data (2024), M4(R4), M4Q(R1), M4Q(R2), M4S(R2), M4E(R2), ACTD, CDSCO Guidance for Industry (Biologicals), COFEPRIS CTD guide v3.0, DS-G-003, DS-REQ-002. See all standards.